BrainFrame ApS

CVR40738215

Core data

Name
BrainFrame ApS
Address
Fugleøjevej 12, 3670, Veksø Sjælland
Founded
Aug 25, 2019
Avg. employees
0
Locations (P-units)
1View locations
Branch
Ikke-finansielle holdingselskaber (642120)

Keep track of BrainFrame ApS

Get an email when we detect changes to financial reports, ownership or management. Save yourself checking the company again.
Free account

Description

Selskabets primære aktivitet består i at besidde kapitalandele i Tetra Pharm Technologies ApS.

Financials

Company financials
Reporting period
2025DKK
Gross profit
-1,213
Operating profit
-1,213
Profit before tax
-864,365
Net income
-1,004,989
Total assets
8,040,095
Equity
6,831,383
Avg. employees
0
2020–2025

Unlock financial history

Datapublica Risk Score

Locked
Assesses the risk of financial distress using the company’s accounts, history, and connections.
Company score
0 · Low100 · High

What goes into the assessment

  • Financials

  • Accounts and history

  • Owners and management

  • Company and connections

Standard: Score and risk bandPro: Also a detailed explanation of the factors

Contact

No contact details have been registered for this company.

Gazelle

Loading gazelle status…

Børsen Gazelle is Dagbladet Børsen's award. Datapublica is not affiliated with Børsen. Calculated statuses are Datapublica's own analysis of public CVR financial-statement data.

Founders

FounderRegistered as founderCurrent rolesOwnership
Martin Stefan RoseRegistered as founderAug 25, 2019Current roles
Management
Ownership
100 %Legal

People

Martin Stefan RoseRoles
ManagementEJERREGISTER
TitlesDIREKTØR

Auditor

Martinsen, Statsautoriseret RevisionspartnerselskabAuditorJørn Dam JensenRolestatsautoriseret revisorFromJul 15, 2026
Ownership100 %Voting rights100 %FromAug 25, 2019

Child companies

Ownership50–66.66 %Voting rights50 %FromJan 15, 2024
Ownership20–24.99 %Voting rights20 %FromOct 10, 2025

Ultimate owners

Martin Stefan Rose
Ownership through
Direct
100 %

Indirectly owned companies

Calculated through shown level 2–3 paths
Tetrapharm Bioengineering ApS
20–24.99 %
Tetrapharm Therapeutics ApS
20–24.99 %

Official sources